PF-Atlas › Mechanisms › Galectin-3 Inhibition
Galectin-3 Inhibition in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Galectin-3 Inhibition is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.
Drugs targeting Galectin-3 Inhibition
Clinical trials
Medical disclaimer. This is a research summary, not medical advice.